Search
Search Results
-
Un lien entre normalisation de l’angiogenèse et stimulation de l’immunité antitumorale
The ultimate goal of using anti-angiogenics for treating cancer is inhibiting angiogenesis and therefore blocking metastatic dissemination. However,...
-
Le prix des médicaments anticancéreux est-il justifié ?
During the recent years, the price of drugs in general and more particularly of anti-cancer molecules have steadily risen and reached such a point...
-
Le mésothéliome péritonéal malin au cours de la fièvre méditerranéenne familiale
IntroductionFamilial Mediterranean fever (FMF) is a hereditary auto-inflammatory disease caused by the mutation of the MEFV gene, which, for several...
-
Difficulté d’application dans les systèmes d’information : le point de vue d’un pharmacien
Since 2014, new reimbursement conditions for high-cost drugs used in oncology have been introduced. Before 2014, reimbursement was automatic for new...
-
Le rôle des modèles murins en immuno-oncologie
Preclinical models in oncology are generally used to test hypotheses generated through basic science. Thus, experiments on murine models are carried...
-
Nouvelle réglementation de l’inscription et radiations des indications de médicaments onéreux de la liste en sus dans les établissements de santé
The “Liste en sus” system, which has been operational since 2004, offers innovations to all patients on the territory and guarantees accessibility to...
-
Stratégies médicales à adopter face aux changements réglementaires concernant la prise en charge des médicaments du cancer (radiation ou non-inscription sur « la liste en sus »)
There are three types of regulation for the use of health products in our daily practice. The first type, at the European level, is regulated by the...